Stockholm - Delayed Quote • SEK
Infant Bacterial Therapeutics AB (publ) (IBT-B.ST)
At close: 5:22 PM GMT+2
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2018) | Next Qtr. (Mar 2019) | Current Year (2018) | Next Year (2019) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2018) | Next Qtr. (Mar 2019) | Current Year (2018) | Next Year (2019) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2018) | Next Qtr. (Mar 2019) | Current Year (2018) | Next Year (2019) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | -14.3 | -29.4 |
| 30 Days Ago | 0 | 0 | -14.3 | -29.4 |
| 60 Days Ago | 0 | 0 | -14.3 | -29.4 |
| 90 Days Ago | 0 | 0 | -14.3 | -29.4 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2018) | Next Qtr. (Mar 2019) | Current Year (2018) | Next Year (2019) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | IBT-B.ST | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 12.10% |
| Current Year | -- | -- | -- | 4.40% |
| Next Year | -- | -- | -- | 13.20% |
| Next 5 Years (per annum) | -- | -- | -- | 10.97% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.2970
+2.41%
EGTX.ST Egetis Therapeutics AB (publ)
5.75
-3.20%
CANTA.ST Cantargia AB (publ)
3.4500
-0.58%
XBRANE.ST Xbrane Biopharma AB (publ)
0.2135
-1.39%
LENZ LENZ Therapeutics, Inc.
15.98
+3.43%
INZY Inozyme Pharma, Inc.
4.4200
+2.08%
MIRM Mirum Pharmaceuticals, Inc.
24.61
+0.49%
FOLD Amicus Therapeutics, Inc.
10.23
+0.59%
KNSA Kiniksa Pharmaceuticals, Ltd.
17.97
+2.04%
RYTM Rhythm Pharmaceuticals, Inc.
38.51
+0.94%